Celera Divests Animal Genomics Business
By Biotechdaily staff writers
Posted on 21 May 2002
The AgGen animal genomics and genotyping business of Celera Genomics (Rockville, MD, USA) has been sold to MetaMorphix, Inc. (Savage, MD, USA). In addition, MetaMorphix has received a subscription to the Celera Discovery System, providing access to Celera's livestock genomic databases. Celera has acquired a minority interest in MetaMorphix and is entitled to share future revenue generated from products developed by MetaMorphix based on Celera's livestock databases.Posted on 21 May 2002
MetaMorphix has 13 products in development, based on three technology platforms: growth factors, genomics/proteomics, and immunopharmaceuticals. The company's products are designed to increase the growth rate and meat production of livestock, improve feed efficiency, reduce waste, and decrease reliance on antibiotics and hormones.
"The creation of livestock genomic databases represents a quantum leap in the development of new products for the animal health and livestock production industries,” said Ed Quattlebaum, Ph.D., chairman, CEO, and president of MetaMorphix. "It is as historic to these industries as similar developments in the human health industry.”
Related Links:
Celera
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Automated Urinalysis Solution
UN-9000
